New Data Suggest Veracyte's Afirma Molecular Testing Capabil

Findings presented at ENDO 2023 also confirm analytical validity of company’s TERT promoter gene mutation testing for thyroid nodule patients

... | June 20, 2023

Related Keywords

United States , Allan Golding , Sina Jasmin , Joshua Klopper , Endocrine Society , Washington University In St , Veracyte Inc , Nasdaq , Twitter , Company Afirma , Afirma Genomic Sequencing Classifier , Memorial Healthcare System , Washington University , Expression Atlas , Annual Report , Quarterly Report ,